Fundz Deep Dive
Everything you need to win CellFE — in one platform.
Who to reach, what to say, and why now on CellFE — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on CellFE — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
CellFE Launches T-Rest ('Resting T Cell Kit') to Enhance CAR-T Cell Therapy Manufacturing
Jan 22, 2025•over 1 year ago
Product Description
CellFE has introduced T-Rest, a novel transfection media product specifically designed for resting T cell workflows in CAR-T cell therapy. This product aims to optimize gene editing workflows, promoting safer and more effective therapies by utilizing resting T cells.
Product Launch Insights
Based on market dataMarket expansion signals
New product launches often coincide with market expansion initiatives